US2008039521A1PendingUtilityA1

Anticancer Effect Enhancer

Assignee: YASUDA HIROYASUPriority: Jun 10, 2004Filed: Jun 10, 2005Published: Feb 14, 2008
Est. expiryJun 10, 2024(expired)· nominal 20-yr term from priority
A61P 35/00A61P 35/02A61P 35/04A61P 43/00A61P 13/08A61P 13/10A61K 31/34
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the present invention is to provide an enhancing agent for effect of anticancer agent for achieving an excellent therapeutic effect on cancer. The enhancing agent for effect of anticancer agent according to the present invention which is a solving means therefor is characterized in that a nitric oxide donor is an effective ingredient. In accordance with the present invention, an excellent therapeutic effect is able to be achieved on non-small cell lung cancer which is still in such a state that no effective therapeutic method has been established yet for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.

Claims

exact text as granted — not AI-modified
1 . An enhancing agent for effect of anticancer agent which is characterized in that a nitric oxide donor is an effective ingredient.  
   
   
       2 . The enhancing agent for effect of anticancer agent according to  claim 1 , wherein the cancer which is an object for the treatment is solid cancer.  
   
   
       3 . The enhancing agent for effect of anticancer agent according to  claim 2 , wherein the solid cancer is non-small cell lung cancer.  
   
   
       4 . The enhancing agent for effect of anticancer agent according to  claim 1 , wherein the nitric oxide donor is an organic nitrate compound.

Join the waitlist — get patent alerts

Track US2008039521A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.